Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
tumor necrosis factor (TNF)
tumor necrosis factor α (TNFα)
tumor suppressor proteins (TSPs)
TURBT
tyrosine kinase domains (TKDs)
tyrosine kinase inhibitor (TKI) Novel Therapeutic Strategies in Oncology Targeted Therapies (Small Molecules) Tyrosine Kinase Inhibitors (TKI)
UDP-glucuronosyl transferase 1A1 (UGT1A1)
UGT1A1
UGTs
ULN
unfolded protein response (UPR)
upper limit of normal (ULN)
UPR
uridine diphosphate glucuronosyltransferases (UGTs)
Vaccines, prophylactic
varicella-zoster virus (VZV)
vascular endothelial growth factor (VEGF) Differentiating Agents and Microenvironment Targeted Therapies (Small Molecules) Targets for Cancer Drugs Vascular Endothelial Growth Factor (VEGF) Receptor
vascular endothelial growth factor receptor (VEGFR)
V domain-containing Ig suppressor of T-cell activation (VISTA)
VEGF
VEGFR
veno-occlusive disease (VOD) Alkylating Agents Transplant-Related Agents
very good partial response (VGPR)
VGPR
VISTA
VOD
VZV
Waldenstrom macroglobulinemia (WM)
WHO
WM